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ABSTRACT
Background: This study intended to assess the severity of Japanese cedar pollinosis using the Practical
Guideline for the Management of Allergic Rhinitis in Japan (PG-MARJ) and the Allergic Rhinitis and its Impact
on Asthma (ARIA) Guideline.
Methods: An Internet questionnaire survey of patients with pollinosis was conducted in mid-May 2011 and re-
sponses were obtained from 3382 individuals who had potential symptoms of Japanese cedar pollinosis from
February to early May 2011 and who had experienced such symptoms for at least two pollen seasons.
Results: According to PG-MARJ, 23.5% of the respondents had severest rhinitis, 29.4% severe rhinitis, 31.3%
moderate rhinitis, 13.8% mild rhinitis and 2.0% asymptomatic rhinitis. According to ARIA, 67.2% of them had
moderatesevere persistent rhinitis, 23.8% moderatesevere intermittent rhinitis, 4.4% mild persistent rhinitis
and 4.6% mild intermittent rhinitis.
Conclusions: Moderate to severe rhinitis was diagnosed in more than 80% of the respondents according to
PG-MARJ, while moderatesevere rhinitis was diagnosed in more than 90% of the respondents according to
ARIA. Most of the respondents suffered relatively severe pollinosis. More than 80% of the respondents had all
the three major symptoms (i.e., sneezing, rhinorrhea and nasal blockage). Disagreement in the severity as-
sessment between the two guidelines was noted in approximately 20% of the respondents.
KEY WORDS
Allergic Rhinitis and its Impact on Asthma (ARIA), Internet survey, pollinosis, Practical Guideline for the Man-
agement of Allergic Rhinitis in Japan (PG-MARJ)
INTRODUCTION
A survey carried out in 20081 revealed that the preva-
lence of perennial allergic rhinitis and seasonal aller-
gic rhinitis (pollinosis) was 23.4% and 29.8%, respec-
tively, and the prevalence of all types of allergic rhini-
tis was as high as 39.4% in Japan. Seasonal allergic
rhinitis in Japan is caused by allergens including pol-
lens of Japanese cedar and cypress in spring, or-
chardgrass in early summer and ragweed and worm-
wood in autumn. Among them, Japanese cedar pollen
is the most important allergen: the prevalence of
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Japanese cedar pollinosis is as high as 26.5% and the
number of patients is increasing year by year. It is as-
sumed that intensive planting of cedar and cypress
trees encouraged by the Japanese forestry policy
from the late 1950s to the 1960s have resulted in a
yearly increase of cedar and cypress pollens dis-
persed from the grown artificial forest leading to the
recent sharp increase of patients with Japanese cedar
pollinosis.
Pollens of cedar and cypress start to fall in Febru-
ary every year and their dispersal is observed until
early May. This large-scale Internet questionnaire
survey was conducted in mid-May 2011 when disper-
sal of cedar and cypress pollens had almost ended.
The subjects of the survey were individuals who had
symptoms of Japanese cedar pollinosis from Febru-
ary to early May 2011 and who had experienced such
symptoms for at least two pollen seasons.
In Japan, the Practical Guideline for the Manage-
ment of Allergic Rhinitis in Japan (PG-MARJ)2 that
describes standard diagnosis and treatment strate-
gies has been widely used and the severity of allergic
rhinitis has been classified based on the three major
symptoms (i.e., sneezing, rhinorrhea and nasal block-
age) into five grades (i.e., severest, severe, moderate,
mild and asymptomatic). On the other hand, the Al-
lergic Rhinitis and its Impact on Asthma (ARIA)
Guideline3 that is regarded as the international guide-
line for allergic rhinitis divides the disease into per-
sistent and intermittent types and classifies the sever-
ity as mild or moderatesevere depending on the dis-
ease’s impact on the daily life activities of the pa-
tients. When the disease type and the severity are
combined, allergic rhinitis can be classified into four
categories: moderatesevere persistent, moderate
severe intermittent, mild persistent and mild intermit-
tent.
This survey included questions about the severity
of symptoms and the impact on daily life activities;
moreover, it intended to assess the severity of Japa-
nese cedar pollinosis according to PG-MARJ and
ARIA and examine differences in their assessment.
METHODS
SURVEY PERIOD
The survey was conducted in the 8-day period from
May 11 to May 18, 2011 when the pollen dispersal
had almost ended.
CONTRACTED RESEARCH COMPANY
ANTERIO Inc. (Tokyo, Japan) was contracted to con-
duct the survey via INTAGE Inc. (Tokyo, Japan), a
net monitor (Cue MonitorYahoo! Research Moni-
tor).
SUBJECTS
Net monitors of INTAGE Inc. have been registered
after strict proof of identity by sending a registration
form to their home address. A broad range of attrib-
utes of monitors including their profile were collected
at recruitment.
All monitors in the country, except those in Hok-
kaido and Okinawa where there are very few patients
with Japanese cedar pollinosis, were screened to se-
lect those who met the following criteria:
(1) Individuals who had potential symptoms of
Japanese cedar pollinosis (e.g., sneezing, nasal dis-
charge, nasal obstruction, itchy eyes and teary eyes)
in the pollen season from February to May 2011.
(2) Individuals who had experienced those symp-
toms for at least two pollen seasons.
(3) Individuals who were not healthcare profession-
als or worked at a publicity agent or market research
company, or had any family member, friend or ac-
quaintance who was a healthcare professional or
worked at a publicity agent or market research com-
pany.
METHODS
This questionnaire survey was conducted on the In-
ternet. Since registered monitors are individuals aged
15 years or older, responses about patients aged 2 to
14 years were given by their mother or female guardi-
ans who were registered as monitors. Specifically,
monitors were asked at screening for the survey
whether they had a child aged less than 15 years who
had potential symptoms of pollinosis from February
to May 2011 and who had had the symptoms in 2010
or before. Monitors who had such a child were asked
to participate in the survey and answered the ques-
tions about their child (only one child even if they
had more than one child with pollinosis).
The policy for use of data obtained in the survey
and protection of personal information was displayed
when the monitors first visited the Web site for the
survey and only those that agreed with the policy
were allowed to answer the questionnaire.
QUESTIONS
The questionnaire consisted of questions that were
prepared based on classifications in PG-MARJ and
ARIA. Responses were used to assess the severity of
the condition in each respondent according to PG-
MARJ and ARIA separately. Generally speaking, In-
ternet survey may be less reliable because the moni-
tors themselves judge the degree of their illness. To
deal with that problem, we made sure that the ques-
tions should be clear so that the monitors wouldn’t
mistake the meaning.
Q1 When did you notice symptoms that could indi-
cate pollinosis (e.g., sneezing, nasal discharge,
nasal obstruction, itchy eyes and teary eyes) ?
Please mark all that apply.
a) February 2011, b) March 2011, c) April 2011,
d) May 2011
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Table　1　Distribution of the respondent population by age
<10 years 10s 20s 30s 40s 50s ≥60 years Total
Male 113 223 237 279 282 243 331 1708 
(50.5%)
Female 128 252 238 277 276 247 256 1674 
(49.5%)
Total 241 
(7.1%)
475 
(14.0%)
475 
(14.0%)
556 
(16.4%)
558 
(16.5%)
490 
(14.5%)
587 
(17.4%)
3382
Q2 When did you visit a medical institution (e.g.,
hospital, clinic) for symptoms of pollinosis or for
the treatmentprevention of pollinosis? Please
mark all that apply.
a) May 2011, b) April 2011, c) March 2011, d)
February 2011, e) January 2011, f) Not from Janu-
ary to May 2011 but in the past, g) Never
Q3 Did you use any over-the-counter (OTC) drug
(sold at a pharmacy or drug store) from February
to May 2011 for symptoms of pollinosis?
a) Yes, b) No
Q4 How often did you experience each of the follow-
ing symptoms in the period with the severest
symptoms? Please select only one for each ques-
tion.
(1) Sneezing (average number of episodes per
day)
a) 21 or more, b) 11 to 20, c) 6 to 10, d) 1 to 5, e)
None
(2) Nasal discharge (average number of blowing
per day)
a) 21 or more, b) 11 to 20, c) 6 to 10, d) 1 to 5, e)
None
(3) Nasal obstruction
a) Complete obstruction all day long
b) Very severe nasal obstruction with mouth
breathing most of the time
c) Severe nasal obstruction with mouth breathing
several times per day
d) Nasal obstruction without mouth breathing
e) No nasal obstruction
Q5 What was the average number of days per week
with any symptoms of pollinosis?
a) 4 or more days per week on average, b) Less
than 4 days per week on average
Q6 How long did the symptoms of pollinosis persist?
a) 4 consecutive weeks or longer, b) Less than 4
consecutive weeks
Q7 Did you have the following during the period with
the severest symptoms?
(1) Sleep disorder
a) Yes, b) No
(2) Disturbance during daily life, leisure andor
sport activities
a) Yes, b) No
(3) Disturbance during school work or work
a) Yes, b) No
(4) Any bothersome symptom
a) Yes, b) No
RESULTS
DEMOGRAPHIC AND OTHER CHARACTERIS-
TICS OF THE RESPONDENTS
In the Internet questionnaire survey conducted be-
tween May 11 and May 18, 2011, responses were ob-
tained from 3382 monitors who had symptoms of pol-
linosis from February to May 2011 (e.g., sneezing, na-
sal discharge, nasal obstruction, itchy eyes and teary
eyes) and who had experienced the symptoms for at
least two pollen seasons. The mean age of the overall
population was 38.2 years (range: 2 to 81 years).
They comprised 1708 males (mean age: 39.3 years)
and 1674 females (mean age: 37.1 years). Table 1
shows the distribution of the respondent population
by age.
As for symptoms of pollinosis, 1655 respondents
(48.9%) had presented the symptoms in February,
2804 (82.9%) in March, 2822 (83.4%) in April, and
1790 (52.9%) in May 2011 (respondents could have
presented the symptoms in more than one period). A
total of 1417 respondents (41.9%) visited a medical in-
stitution for symptoms of pollinosis or for the treat-
mentprevention of pollinosis between January and
May 2011, while 1133 respondents (33.5%) did not
visit any medical institution in that period but had vis-
ited one before and 832 respondents (24.6%) had
never visited any medical institution. In addition,
1080 respondents (31.9%) used OTC drugs for symp-
toms of pollinosis
SEVERITY ACCORDING TO PG-MARJ
Figure 1 shows the severity in the period with the se-
verest symptoms in 3382 respondents: (1) sneezing
(average number of episodes per day), (2) nasal dis-
charge (average number of blowing per day) and (3)
nasal obstruction (degree). Based on the severity of
these three symptoms, the severity of rhinitis in each
respondent was assessed using the five-grade classifi-
cation of PG-MARJ. As a result, 795 respondents
(23.5%) had severest rhinitis, 995 (29.4%) severe
rhinitis, 1057 (31.3%) moderate rhinitis, 468 (13.8%)
mild rhinitis and 67 (2.0%) asymptomatic rhinitis. In
addition, the disease type was determined based on
the combination of severity of sneezing, rhinorrhea
and nasal blockage. The distribution of disease type
in the 3382 respondents is shown in Table 2. Actually,
Gotoh M et al.
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Fig.　1　Symptoms of pollinosis according to PG-MARJ.
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82.0% of the overall population had all three major
symptoms (i.e., sneezing, rhinorrhea and nasal block-
age). The severity by age group is shown in Figure 2.
SEVERITY ACCORDING TO ARIA
1) Disease type
In the ARIA Guideline, the term “persistent” de-
notes presence of symptoms for 4 days per week
and for 4 weeks, while the term “intermittent” de-
notes presence of symptoms for <4 days per week or
for <4 weeks. The average number of days with the
symptoms of pollinosis per week was4 days in 2750
respondents (81.3%) and <4 days in 632 respondents
(18.7%). The duration of the symptoms was 4 weeks
in 2675 respondents (79.1%) and <4 weeks in 707 re-
spondents (20.9%).
Based on the above results, 2423 patients (71.6%)
had persistent rhinitis (with symptoms for 4 days
per week and for 4 weeks) and 959 patients (28.4%)
had intermittent rhinitis.
2) Severity
Figure 3 summarizes the presence of (1) sleep dis-
order, (2) disturbance during daily life, leisure and
or sport activities, (3) disturbance during school
work or work and (4) any bothersome symptom dur-
ing the period with the severest symptoms of pollino-
sis. According to ARIA, presence of any of these four
conditions [ (1) to (4) ] is regarded as moderatese-
vere rhinitis, and absence of all of them as mild rhini-
tis. Based on the replies to these questions, 3079 re-
spondents (91.0%) had moderatesevere rhinitis and
303 respondents (9.0%) had mild rhinitis.
3) When ARIA was applied to the above replies
from 3382 respondents, 2274 respondents (67.2%)
had moderatesevere persistent rhinitis, 805 (23.8%)
moderatesevere intermittent rhinitis, 149 (4.4%)
mild persistent rhinitis and 154 (4.6%) mild intermit-
tent rhinitis. The distribution of the overall population
by severity and age group is shown in Figure 4.
PROPORTION OF RESPONDENTS VISITING A
MEDICAL INSTITUTION
The proportion of respondents visiting a medical in-
stitution was calculated for each degree of severity
determined separately according to PG-MARJ and
ARIA. In the overall population, 41.9% of the respon-
dents visited a medical institution for symptoms of
suspected pollinosis between January and May 2011,
while 33.5% did not during that period but had visited
a medical institution before. Thus, 75.4% had visited a
medical institution regardless of the time and 24.6%
had never visited one. As shown in Figure 5, respon-
dents were more likely to have visited a medical insti-
tution as the severity level according to PG-MARJ in-
creased. However, approximately 20% of the respon-
dents with severest or severe rhinitis had never vis-
ited a medical institution for pollinosis. On the other
hand, respondents considered to have persistent
rhinitis according to ARIA were more likely to have
visited a medical institution than those considered to
have intermittent rhinitis, as shown in Figure 6. In
the overall population, 31.9% used OTC drugs be-
tween February and May 2011. Of the 1417 respon-
dents who visited a medical institution between Janu-
ary and May 2011, 17.3% used OTC drugs in contrast
to 48.2% of the 1133 respondents who did not visit any
medical institution during the same period but who
had visited a medical institution before and 34.7% of
the 832 respondents who had never visited any medi-
cal institution.
CORRELATION OF SEVERITY ASSESSMENT
BETWEEN PG-MARJ AND ARIA
Figure 7 shows the severity classification according
to ARIA for subgroups of respondents defined ac-
cording to PG-MARJ (i.e., severest, severe, moderate,
mild and asymptomatic). As a result, 79.7% of 468 re-
spondents considered to have mild rhinitis and 67.2%
of 67 respondents considered to have asymptomatic
rhinitis according to PG-MARJ had moderatesevere
Severity Assessment by PG-MARJ & ARIA
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Fig.　2　Severity by age group according to PG-MARJ.
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Table　2　Distribution of disease type according to PG-MARJ
Severity
Sneezing fit or rhinorrhea†
++++ +++ ++ + -
Nasal
blockage
++++ 2.5% 1.9% 1.6% 0.8% 0.2%
+++ 6.7% 5.6% 5.3% 2.1% 0.3%
++ 5.5% 8.4% 10.2% 5.4% 0.7%
+ 3.0% 5.2% 10.4% 7.5% 1.0%
- 1.3% 2.5% 4.6% 5.4% 2.0%
Total (n = 3382)
†Select more severe one, sneezing or rhinorrhea.
++++, Severest; +++, Severe; ++, Moderate; +, Mild; -, Asymptomatic.
rhinitis according to ARIA.
AGREEMENT OF SEVERITY ASSESSMENT BE-
TWEEN ARIA AND PG-MARJ
Respondents were grouped by severity according to
PG-MARJ and ARIA into the following four catego-
ries: ARIA mild rhinitis and PG-MARJ severestse-
veremoderate rhinitis, ARIA severemoderate rhini-
tis and PG-MARJ mildasymptomatic rhinitis, ARIA
mild rhinitis and PG-MARJ mildasymptomatic rhini-
tis, and ARIA severemoderate rhinitis and PG-MARJ
severestseveremoderate rhinitis.
Thus, 117 respondents (3.5%) had mildasympto-
matic rhinitis according to both guidelines and 2661
respondents (78.7%) had moderate or more severe
rhinitis. On the other hand, 418 respondents (12.4%)
who had moderatesevere rhinitis according to ARIA
had mildasymptomatic rhinitis according to PG-
MARJ, while 186 respondents (5.5%) who had mild
rhinitis according to ARIA had moderate or more se-
vere rhinitis according to PG-MARJ. This means that
severity assessment by the two guidelines did not
agree in 17.9% of the respondents. The distribution of
the four categories by age group is shown in Figure
8. The disagreement rate was higher in the age group
of <10 years (25.3%) and that of60 years (22.0%).
DISCUSSION
In order to determine the severity of symptoms in pa-
tients with springtime pollinosis, an Internet ques-
tionnaire survey was conducted between May 11 and
May 18, 2011 when the cedar and cypress pollen dis-
persal season (from February to early May) had al-
ready ended, in individuals who had symptoms of pol-
linosis in the current pollinosis season and who had
experienced those symptoms for at least two pollen
seasons.
In Japan, the Practical Guideline for the Manage-
ment of Allergic Rhinitis in Japan (PG-MARJ) was
first established in 1993 to improve treatment for al-
Gotoh M et al.
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Fig.　3　Disease’s impact on daily life activities according to ARIA.
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Fig.　4　Severity by age group according to ARIA.
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lergic rhinitis and now the 2009 revised version (Ver-
sion 6) is being widely used.2,4,5 The classification of
severity in this guideline was used to assess the
symptoms in the current season in each of the survey
respondents. As a result, more than half of the re-
spondents were considered to have severest or se-
vere rhinitis and more than 80% to have moderate or
more severe rhinitis. Severest or severe rhinitis was
most prevalent in the respondents in their 20s and
30s (approximately 60%). In addition, more than 80%
of all respondents had the three major symptoms
(i.e., sneezing, rhinorrhea and nasal blockage). Ap-
proximately 2% of the respondents were considered
to have asymptomatic rhinitis. Probably because the
PG-MARJ classification of severity depends on the
three major symptoms and does not take into account
eye symptoms (itchy eyes and teary eyes), respon-
dents who had eye symptoms alone may have been
deemed to have asymptomatic rhinitis.
According to ARIA, due to symptoms of pollinosis,
approximately one third of the respondents com-
plained of sleep disorder, about half complained of
disturbance during daily life, leisure andor sport ac-
tivities or schoolwork, and more than 80% com-
plained of bothersome symptoms. According to
ARIA, approximately 90% of the respondents had
moderatesevere rhinitis and approximately 10% had
mild rhinitis. Based on the duration of symptoms, ap-
Severity Assessment by PG-MARJ & ARIA
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Fig.　5　Proportion of respondents visiting a medical institution by severity according to PG-MARJ.
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Fig.　6　Proportion of respondents visiting a medical institution by severity according to ARIA.
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proximately 70% of the respondents had persistent
rhinitis and approximately 30% had intermittent rhini-
tis. Based on the combination of disease type and se-
verity, 2274 respondents (67.2%) had moderatese-
vere persistent rhinitis, 805 (23.8%) moderatesevere
intermittent rhinitis, 149 (4.4%) mild persistent rhini-
tis and 154 (4.6%) mild intermittent rhinitis. The
analysis by age group indicated that younger respon-
dents were less likely to have persistent rhinitis but
more likely to have intermittent rhinitis.
It was naturally expected that the distribution of se-
verity would vary among different causal antigens
and among different geographical regions. A survey
conducted in Europe where ARIA has been widely
used reported that the proportion of mild intermit-
tent, mild persistent, moderatesevere intermittent
and moderatesevere persistent rhinitis was 10%,
14%, 17% and 59%, respectively.6 This result showed
less imbalance in different severity classes compared
to the result of the present survey of Japanese cedar
pollinosis. However, it has been reported that 90% of
the patients seen at medical institutions had moder-
atesevere rhinitis7,8 as is the case in the present sur-
vey. This means that the results may vary depending
not only on antigens and geographical regions but
also on the type of medical institutions where patients
are seen. In the present survey, 41.9% of the 3382 re-
spondents visited a medical institution between Janu-
ary and May 2011 and 17.3% used OTC drugs, while
42.5% did not visit any medical institution in the cur-
rent pollen season and more than 40% of them used
OTC drugs. Moreover, approximately 40% of the re-
Gotoh M et al.
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Fig.　7　Correlation of severity assessment between PG-MARJ and ARIA.
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Fig.　8　Agreement of severity assessment between ARIA and PG-MARJ.
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Disagreement rate of the severity assessment 17.9%
spondents who used OTC drugs experienced drowsi-
ness as a side effect (data not shown). The main-
stream OTC oral drugs for the relief of pollinosis
symptoms include first- and second-generation anti-
histaminics, which may cause drowsiness. The first-
generation antihistaminics, which may cause severe
drowsiness and dizziness and have a strong anti-
cholinergic effect, are contraindicated in patients with
glaucoma, benign prostatic hypertrophy and asthma.
Concomitant use of other medications for the treat-
ment of concurrent diseases or use of such OTC
drugs without the supervision of a physician by pa-
tients who are engaged in driving or potentially haz-
ardous activities is extremely dangerous and may
cause decreased operating efficiency even during
non-hazardous work or decreased academic perform-
ance. The results of the present survey indicate that it
is necessary to improve awareness concerning aller-
gic rhinitis (especially pollinosis) in the general pub-
lic.
Severity assessment according to PG-MARJ and
ARIA revealed higher prevalence of ARIA-defined
persistent rhinitis and moderatesevere rhinitis in in-
dividuals with severer disease according to PG-
MARG. This result indicates a positive correlation be-
tween the two guidelines. However, as high as ap-
proximately 80% and 70% of the respondents consid-
ered to have mild and asymptomatic rhinitis, respec-
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tively, according to PG-MARG were deemed to have
moderatesevere rhinitis according to ARIA. The dis-
agreement rate of the severity assessment was ap-
proximately 18% in the overall population. The analy-
sis by age group revealed higher disagreement rates
of approximately 25% and 22% in the age group of <10
years and in that of 60 years, respectively. Probably
because the severity classification in ARIA depends
mainly on the impact on the quality of life (QOL) of
patients, patients who had only mild symptoms but
felt a large impact on daily life activities were likely to
be classified as having moderate or more severe
rhinitis. The classification in ARIA, which uses “pres-
ence or absence of bothersome symptoms” alone to
assess the severity of nasal symptoms, may not accu-
rately reflect the degree of nasal symptoms them-
selves.
The results of the present survey indicated that the
majority of patients with Japanese cedar pollinosis
had severe disease: more than 80% of the individuals
who had symptoms of pollinosis during the current
pollinosis season had moderate or more severe rhini-
tis according to PG-MARJ and more than 90% moder-
atesevere rhinitis according to ARIA. The classifica-
tion system of ARIA may provide an incorrect diagno-
sis of severity since it may classify patients with se-
vere nasal symptoms as having mild rhinitis. On the
contrary, PG-MARG, which has been prepared based
on the real conditions of allergic rhinitis in Japan, is
considered to be a useful guideline in clinical prac-
tice.
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